You are here:
Gavi’s two funding streams, innovative finance and direct contributions account for 31% and 69% respectively of the Vaccine Alliance’s overall funding portfolio.
Multi-year pledges and commitments are crucial to sustaining Gavi's ongoing programmes and its ability to fund new vaccines.
Public-private partnerships Corporations, private individuals & foundations play a vital role in meeting Gavi needs, accounting for 23% of 2000 to 2014 funding.
Cultivation of key public & private donor relationships, co-financing, shaping vaccine markets and mobilising civil society advocacy.
More than seven million future deaths averted from hepatitis B, Haemophilus influenzae type B, measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever since Gavi's launch in 2000.
01 May 2015
Immunisation gives children chance to live life to full potential
22 April 2015
The imperative of closing the immunization gap
24 March 2015
Be Bold: How Gavi Will Immunise Another 300 Million Children
18 March 2015
How to Fight the Next Epidemic
The New York Times
Share the risks of Ebola vaccine development
06 March 2015
Bill Gates: Why I'm betting on the Gulf to help fight extreme poverty and disease
19 February 2015
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here